Investigating the Role of Herbal Plant mixtures in the Management of Poly Cystic Ovary Syndrome (A Randomized double blinded placebo controlled clinical trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047382

Enrollment

Unknown

Registered

2021-06-13

Start date

2021-05-20

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poly Cystic Ovary

Interventions

1:tea herbal

2:placebo

Eligibility

Sex/Gender

Male

Age

16 Years to 40 Years

Inclusion criteria

Inclusion criteria: 16 to 40 years age women, will be proved to have PCOS according to Rotterdam Criteria.

Exclusion criteria

Exclusion criteria: 1. Menarche less than one year; 2. Who have any chronic illness example: renal disease, diabetes, hypertension, thyroid disease, or bleeding tendency; 3. Who are on long term pharmacological treatments; 4. Who are on conventional therapy for PCOS; 5. Who are pregnant; 6. Those who are using any herbal treatment.

Design outcomes

Primary

Measure	Time frame
The primary outcome of the current research will be the level of the hormone (FSH, LH, AMH, total testosterone, free testosterone, DHEAs, lipid profile, fasting insulin, TSH, FBS, sex hormone binding globulin, prolactin, FTSH);	—

Secondary

Measure	Time frame
The secondary outcome will be the other clinical measurements including (Blood pressure, BMI, WHR);	—

Countries

Iraq

Contacts

Public ContactJeza Muhamad Abdul Aziz

Department of Medical Laboratory of Science, College of Health Sciences, University of Human Development, Sulaimani, Kurdistan Regional Government, Iraq 7Baxshin Research Centre, Baxshin Hospital, Su

jeza1981@gmail.com+9647700559681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026